National Capital Community Meeting
VirtualJoin us for our upcoming community meeting via video conference!
7:00 pm - 8:00 pm
7:00 pm - 8:30 pm
To help answer your questions about clinical trials, the Rogosin Institute, a PKD Foundation Center of Excellence, launched the Rogosin Advanced Research Series.
To help answer your questions about clinical trials, the Rogosin Institute, a PKD Foundation Center of Excellence, launched the Rogosin Advanced Research Series. In this first webinar, James Chevalier, M.D., will deep dive into the clinical trial for corrector molecules.
No registration is required for this webinar, simply click the link below to join.
About Corrector Molecules (The “Protein Fixer”):
How it works: Think of your kidney cells like a factory that needs a specific instruction manual to produce polycystin proteins, which keep the kidneys healthy. In many people with PKD, the manual is slightly “mis-written with a typo,” causing the protein to fold into the wrong shape. Because it’s misfolded, the body can’t use the abnormal polycystin protein. Corrector molecules is a small molecule that works as a protein corrector. It finds those misfolded proteins and helps them fold into the correct shape so they can get back to work, helping your kidneys.
Administration: If you qualify, this medication is taken as an oral pill.
Who Qualifies: This is a highly specialized precision drug. Currently, it is only designed for patients with a very specific subset of PKD1 gene variants. We estimate that less than 10% of the PKD population will qualify for this particular study based on their genetic profile.
Webinar Details:
Topic: Corrector Molecules and the Genetics of PKD
Date: Thursday, April 30th
Time: 7:00 PM – 8:30 PM
Link to Join: Join our Cloud HD Video Meeting (No registration required—just click to join!)
Your Privacy: We want everyone to feel comfortable attending. Please note that participants will not be seen, but your screen name will be visible to the group. You will be able to ask questions during the session.
Next Steps & Reminders:
Genetic Testing: If you have not yet had your genetic testing done, please contact Susan for an appointment.
Trial Eligibility: You must be an active patient at Rogosin to join a Rogosin research trial. However, this webinar is open to the public, so feel free to share the link with anyone in the broader PKD community who may want to learn more about the genetics of PKD and corrector molecules.
Questions? If you have any questions, please reach out to Susan at 646-317-0715 or SUA9031@nyp.org.
If you cannot make it live, we will record the presentation and upload it to our YouTube channel and Apple Podcasts.
We will share the schedule for our upcoming farabursen webinar in the near future.
Join us for our upcoming community meeting via video conference!
Research Reflections: Voices of Clinical Trial Participants University of Maryland PKD Clinic
Enjoy an evening of gaming, live music, drinks and hors d'oeuvres for a cause. Proceeds benefit the PKD Foundation, whose mission is to give hope by funding research, advocating for patients and building a community for all impacted by PKD.
Join us for an in person meeting focused on connection, conversation and learning.
Meet & Greet with Mount Sinai Partner Clinic: Advances in PKD Care & Diagnosis Updates